Showing results (1351-1360 of 2,132) with videos related to
Sort By:
Pageof 214
Biopharmaceutics & Drug Disposition|January 1, 1982
The effect of hydralazine on the pharmacokinetics of three different beta adrenoceptor antagonists: metoprolol, nadolol, and acebutololD B Jack, M J Kendall, S Dean, et al.Biopharmaceutics & Drug Disposition|April 1, 1981
Bioavailability of terfenadine in manR A Okerholm, D L Weiner, R H Hook, et al.Biopharmaceutics & Drug Disposition|February 9, 2010
Formulation and biopharmaceutical evaluation of a transdermal patch containing letrozoleLi Li, Liang Fang, Xinlan Xu, et al.Biopharmaceutics & Drug Disposition|July 1, 1997
Pharmacokinetics of acebutolol enantiomers after intravenous administration of racemate in a rat model: a dosing range comparisonS A Mostafavi, R T FosterBiopharmaceutics & Drug Disposition|July 1, 1993
Pharmacokinetics of diacerein in patients with liver cirrhosisO Magnard, K Louchahi, M Tod, et al.Biopharmaceutics & Drug Disposition|August 1, 1993
Pharmacokinetics of naproxen, its metabolite O-desmethylnaproxen, and their acyl glucuronides in humansT B Vree, M van den Biggelaar-Martea, C P Verwey-van Wissen, et al.Biopharmaceutics & Drug Disposition|October 14, 2009
In vitro-in vivo correlation of modified release dosage form of lamotrigineHiten J Shah, Gunta Subbaiah, Dasharath M Patel, et al.Biopharmaceutics & Drug Disposition|December 17, 2009
Effects of 1alpha,25-dihydroxyvitamin D3 on transporters and enzymes of the rat intestine and kidney in vivoEdwin C Y Chow, Huadong Sun, Ansar A Khan, et al.Biopharmaceutics & Drug Disposition|November 23, 2005
Gender differences in the pharmacokinetics of DA-6034, a derivative of flavonoids, in ratsSi H Yang, Soo K Bae, Jong W Kwon, et al.Biopharmaceutics & Drug Disposition|October 29, 2009
Effects of obesity induced by high-fat diet on the pharmacokinetics of nelfinavir, a HIV protease inhibitor, in laboratory ratsNobuyuki Sugioka, Kenta Haraya, Keizo Fukushima, et al.Pageof 214